SAB Biotherapeutics, Inc. Warrant
SABSWStock
$0.01
Market Cap—
P/E—
Div yield—
Beta-0.00
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-42.85%
Price vs S&P 500 (4W)9.33%
VGM Score37.43
Industry Peers — Biological Products(180)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SABSWSAB Biotherapeutics, Inc. Warrant | — | — | D | $0.01 |
| AMGNAmgen Inc | C | C | C | $371.58 |
| GILDGilead Sciences Inc | C | B | C | $136.30 |
| ARGXargenx SE American Depositary Shares | D | A | B | $857.97 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $179.18 |
| BIIBBiogen Inc. Common Stock | B | D | B | $208.92 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.56 |
| MRNAModerna, Inc. Common Stock | D | B | B | $63.15 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $171.55 |
| EXELExelixis Inc | C | B | B | $55.68 |
| TECHBio-Techne Corp. | D | C | B | $71.77 |
About
SAB Biotherapeutics is a clinical-stage biopharmaceutical company developing targeted human polyclonal antibodies using its proprietary DiversitAb platform. The company uses genetically modified cattle to produce human antibodies without relying on human plasma or serum, offering a differentiated manufacturing approach. This technology enables rapid production of high-volume therapeutic antibodies, potentially providing a competitive advantage in immunotherapy development.